EV/EBITDA:
-21.72+1.30(+5.65%)Summary
- As of today (September 15, 2025), TARS EV/EBITDA is -21.72, with a rise of +1.30 (+5.65%) during the most recent trading session on September 12, 2025.
- Over the past year, TARS EV/EBITDA has dropped by -14.69 (-208.96%).
- TARS EV/EBITDA is now -964.71% below its all-time high of -2.04.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.7% | -5.6% | -4.8% |
| 1 m1 month | +10.4% | -10.3% | -8.9% |
| 3 m3 months | -49.2% | +28.4% | +20.7% |
| 6 m6 months | -30.3% | -0.4% | +2.6% |
| ytdytd | -21.9% | -6.8% | -10.8% |
| 1 y1 year | -209.0% | +75.1% | +48.4% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -21.72 | at high | -26.63 | +18.4% |
| 3 m | 3-month | -13.91 | -56.1% | -26.63 | +18.4% |
| 6 m | 6-month | -13.91 | -56.1% | -26.63 | +18.4% |
| 1 y | 1-year | -6.45 | -236.7% | -26.63 | +18.4% |
| 3 y | 3-year | -2.04 | -964.7% | -26.63 | +18.4% |
| 5 y | 5-year | -2.04 | -964.7% | -126.17 | +82.8% |
| alltime | all time | -2.04 | -964.7% | -126.17 | +82.8% |
TARS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -21.72(+21.9%) |
| 2024 | -17.82(+372.7%) |
| 2023 | -3.77(+15.3%) |
| Date | Value |
|---|---|
| 2022 | -3.27(-86.1%) |
| 2021 | -23.56(-5.8%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of TARS is -21.72
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high EV/EBITDA is -2.04
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals, Inc. EV/EBITDA has changed by -3.90 (-21.89%) since the beginning of the year
What is Tarsus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -14.69 (-208.96%)